Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BigOmics Analytics is a Swiss bioinformatics company specializing in the development of user-friendly platforms for the analysis and visualization of complex omics data. Their flagship product, Omics Playground, is a self-service tool that enables biologists and clinicians to perform advanced transcriptomics and proteomics analysis without the need for programming expertise. By automating routine bioinformatics tasks, the company accelerates the drug discovery process and facilitates biomarker identification for pharmaceutical and biotech organizations. BigOmics aims to bridge the gap between data generation and biological insight, empowering researchers to make data-driven decisions more efficiently. The company operates as a spin-off from the Institute of Oncology Research and the Dalle Molle Institute for Artificial Intelligence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BigOmics Analytics.